This research consists of three separate but related papers on barriers to immunization services and health policy. Although these issues are relevant for all immunization services, the focus is on hepatitis A (HAV) and hepatitis B (HBV). There are supply barriers, which inhibit providers of care from reaching those in need of immunization, and demand barriers, which prevent patients from accessing services. These papers address aspects of supply barriers. The first paper addresses the question of who should be immunized against HAV when target groups are not clearly identified. Various risk groups were analyzed regarding the comparative risk of contracting and transmitting hepatitis A. This analysis recommends that the following groups ...
Barriers to immunization are seen in both the general population and the health care workforce. We c...
Current issues that are associated with the development of hepatitis B vaccine, combination vaccines...
IMPORTANCESince licensure of the human papillomavirus (HPV) vaccine in 2006, HPV vaccine coverage am...
Introduction: Hepatitis B virus (HBV) infection remains a serious risk for health care workers (HCWs...
Pittsburgh, Pennsylvania, among other major American cities, is seeing a sharp rise in Hepatitis A c...
Objective. To analyze factors associated with hepatitis B immunization adherence among adolescents a...
In produced countries, including the United States, hepatitis A infection continues to be an importa...
The following groups are at increased risk of contracting or having severe outcomes from hepatitis A...
The benefits of vaccination are clearly demonstrated by the eradication or enormous decline in the i...
Hepatitis B is a serious public health problem leading to chronic infection, liver cirrhosis, and he...
AbstractThe benefits of vaccination are clearly demonstrated by the eradication or enormous decline ...
Health-care providers (HCPs) are at increased risk for exposure to vaccine-preventable diseases (VPD...
Hepatitis A and B vaccine coverage is suboptimal in US adults, even among those at increased risk fo...
Background: Hepatitis B virus (HBV) infection causes significant morbidity and mortality worldwide. ...
Background: Hepatitis B (HBV) is one of the greatest health disparities among Asian Americans. A tea...
Barriers to immunization are seen in both the general population and the health care workforce. We c...
Current issues that are associated with the development of hepatitis B vaccine, combination vaccines...
IMPORTANCESince licensure of the human papillomavirus (HPV) vaccine in 2006, HPV vaccine coverage am...
Introduction: Hepatitis B virus (HBV) infection remains a serious risk for health care workers (HCWs...
Pittsburgh, Pennsylvania, among other major American cities, is seeing a sharp rise in Hepatitis A c...
Objective. To analyze factors associated with hepatitis B immunization adherence among adolescents a...
In produced countries, including the United States, hepatitis A infection continues to be an importa...
The following groups are at increased risk of contracting or having severe outcomes from hepatitis A...
The benefits of vaccination are clearly demonstrated by the eradication or enormous decline in the i...
Hepatitis B is a serious public health problem leading to chronic infection, liver cirrhosis, and he...
AbstractThe benefits of vaccination are clearly demonstrated by the eradication or enormous decline ...
Health-care providers (HCPs) are at increased risk for exposure to vaccine-preventable diseases (VPD...
Hepatitis A and B vaccine coverage is suboptimal in US adults, even among those at increased risk fo...
Background: Hepatitis B virus (HBV) infection causes significant morbidity and mortality worldwide. ...
Background: Hepatitis B (HBV) is one of the greatest health disparities among Asian Americans. A tea...
Barriers to immunization are seen in both the general population and the health care workforce. We c...
Current issues that are associated with the development of hepatitis B vaccine, combination vaccines...
IMPORTANCESince licensure of the human papillomavirus (HPV) vaccine in 2006, HPV vaccine coverage am...